We've found
7,711
archived clinical trials in
Depression
We've found
7,711
archived clinical trials in
Depression
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Lurasidone Pediatric Bipolar Study
Updated: 11/20/2017
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Preventing Postpartum Depression in Prenatal Care
Updated: 11/20/2017
Bellevue ROSE: Preventing Postpartum Depression in Prenatal Care
Status: Enrolling
Updated: 11/20/2017
Preventing Postpartum Depression in Prenatal Care
Updated: 11/20/2017
Bellevue ROSE: Preventing Postpartum Depression in Prenatal Care
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
Preventing Depression in People Receiving Mechanical Ventilation in an Intensive Care Unit
Updated: 11/21/2017
Feasibility Study to Prevent Post-ICU Depression
Status: Enrolling
Updated: 11/21/2017
Preventing Depression in People Receiving Mechanical Ventilation in an Intensive Care Unit
Updated: 11/21/2017
Feasibility Study to Prevent Post-ICU Depression
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
Updated: 11/21/2017
BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Treatment for Major Depressive Disorder in Adult Females
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials